Company: MVIS
Filing Date: 2025-03-26
Form Type: 10-K
Source: 0001641172-25-000783
Chunk: 256

Company: MICROVISION, INC.
Filing Date: 2025-03-26
Form: 10-K
Item: Item 2
Chunk 256
---
 31, 2023, we issued 5.0 million shares of our common stock for net proceeds of $12.5 million under
    the agreement. The sales agreement was terminated in June 2023.

    ●
    In
    June 2023, we entered into a $45.0 million ATM equity offering agreement with Craig-Hallum. Under the agreement, we were able, at
    our discretion, to offer and sell shares of our common stock having an aggregate value of up to $45.0 million through Craig-Hallum.
    As of June 30, 2023, we had completed sales under such sales agreement, having sold 10.9 million shares for net proceeds of $43.9
    million. No further shares are available for sales under this agreement.

Our
capital requirements will depend on many factors, including, but not limited to, the rate at which OEMs and other potential customers
introduce products incorporating our technology and the market acceptance and competitive position of such products. Our ability to raise
capital will depend on numerous factors, including the following:

    ●
    Perceptions
    of our ability to continue as a going concern;

    ●
    Market
    acceptance of products incorporating our technology;

    ●
    Changes
    in evaluations and recommendations by any securities analysts following our stock or our industry generally;

    ●
    Announcements
    by other companies in our industry;

    ●
    Changes
    in business or regulatory conditions;

    ●
    Announcements
    or implementation by our competitors of technological innovations or new products;

    ●
    The
    status of particular development programs and the timing of performance under specific development agreements;

    ●
    Economic
    and stock market conditions;

    ●
    The
    cost of filing, prosecuting, defending and enforcing any patent claims and other intellectual property rights;

    ●
    Our
    ability to establish cooperative development or licensing arrangements; 

    ●
    Our authorized shares available for sale; or

    ●
    Other
    factors unrelated to our company or industry.

If
we are successful in establishing OEM co-development arrangements, we may receive full or partial funding for certain non-recurring engineering
costs for technology development and/or product development. Nevertheless, we expect our capital requirements to remain high as we expand
our activities and operations with the objective of commercializing our technology.

29

Recent
Accounting Pronouncements 

See
Note